FDA approved Merck’s Dulera, a combination inhaler, for asthma patients 12 years and older, the company announced today. Dulera consists of an inhaled corticosteroid and a long-acting beta agonist, ...
HONOLULU--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from two 26-week investigational Phase III clinical studies evaluating the ...
asthma inhaler overweight The FDA has approved updated labeling for Asmanex HFA (mometasone furoate; Merck) and Dulera (mometasone furoate, formoterol fumarate; Merck) to include use in pediatric ...
June 28, 2010 — The US Food and Drug Administration (FDA) has approved Dulera (Merck & Co, Inc) inhalation aerosol containing a combination of mometasone furoate and formoterol fumarate dihydrate for ...
ATS 2024, San Diego – Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback